Advocacy

NCCAR advocates on behalf of the commercial real estate broker, taking positions (when needed within our industry) and working with those involved toward favorable results.  Our government affairs committee informs and educates our membership on upcoming issues and changes to business due to new legislation or government issues.  NCCAR is diligently working to stay on top of Commercial related issues that are happening within Northern Colorado.  NCCAR is currently working and watching the Change of Use issue in Fort Collins.  More info on this issue to come!

NAR’s Commercial Issues and Actions

Commercial-Issues-and-Actions-8-20-2014

CALLS TO ACTION

(Will post here when announced)

REALTOR PARTY

RPAC22_Major-Investor-Commercial-Brochure_DIGITAL_FINAL2

The work we do as REALTORS®, and as an organization, is noble, good, and lasting.  Voting is opportunity to exemplify and solidify this point.

SIGN UP HERE FOR REALTOR PARTY MOBILE ALERTS

Click the link above and enter your mobile phone number and your name to start receiving REALTOR® Party Mobile alerts. NAR will send you short text messages when we need you to take action on important real estate issues (usually only three to five times per year). If you have questions about the REALTOR® Party Mobile Alerts, please contact comments@realtoractioncenter.com.

VOTING POLLING PLACE IN NORTHERN COLORADO FOR 2022

https://www.larimer.gov/clerk/elections/voting-and-drop-locations#/map/ALL

https://www.weldgov.com/files/sharedassets/public/departments/clerk-and-recorder/documents/elections/2022-primary-cx-v1-voter-times-and-places-info-sheet.pdf

 

NCCAR will continue to post pertinent information and links regarding COVID19 to this page regularly. It is important to keep our members and communities safe during this time with correct information.

Want up to date information on COVID19 and Realtors?

Then do so by using REALTOR® Party.

Mobile Alerts (RPMA), REALTORS® can now text COVID19 to 30644 to get information on our ongoing advocacy efforts with COVID19.